Navigation Links
Oncolytics Biotech Inc. Collaborators to Present Combination REOLYSIN(R) and Paclitaxel/Carboplatin Results at iSBTc Annual Meeting
Date:10/23/2008

CALGARY, Oct. 23 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) today announced that an abstract entitled "Phase I Trial of Oncolytic Reovirus (REOLYSIN(R)) in Combination with Carboplatin/Paclitaxel in Patients with Advanced Solid Cancers" will be available in the November/December issue of the Journal of Immunotherapy, the official journal of the International Society for Biological Therapy of Cancer (iSBTc). The principal investigator for the trial is Dr. Kevin Harrington of The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust.

The abstract covers results of the trial (REO 011) up to July 2008. At that time, 11 patients had received 46 cycles of treatment, with no dose-limiting toxicities. Of the 10 evaluable patients, there were three patients with a partial response, five patients with stable disease and two patients with progressive disease. On the basis of promising response data in the patients with head and neck cancers, a Phase II study has been opened in head and neck cancer patients using the 3x10(10) TCID(50) dose on five consecutive days.

A poster presentation that will include current results of the trial is scheduled to be presented on November 1, 2008 at the iSBTc annual meeting. The meeting is being held in San Diego, California from October 31-November 2, 2008.

The poster should be available on the Oncolytics website at http://www.oncolyticsbiotech.com on November 3, 2008.

About Oncolytics Biotech Inc.

Oncolytics is a Calgary-based biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics. Oncolytics' clinical program includes a variety of Phase I/II and Phase II human trials using REOLYSIN(R), its proprietary formulation of the human reovirus, alone and in combination with radiation or chemotherapy. For further information about Oncolytics, please visi
'/>"/>

SOURCE Oncolytics Biotech Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Oncolytics Biotech Inc. Announces Issuance of 23rd U.S. Patent
2. Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
3. Media Advisory - Oncolytics Biotech Inc. to Present at BioPartnering Europe
4. Media Advisory - Oncolytics Biotech Inc. to Present at BIO InvestorForum 2007
5. Oncolytics Biotech Inc. Announces Approval for U.K. Clinical Trial Investigating REOLYSIN(R) in Combination with Cyclophosphamide
6. Oncolytics Biotech Inc. Collaborators to Present Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
7. Oncolytics Biotech Inc. Announces 2007 Third Quarter Results
8. Media Advisory - Oncolytics Biotech Inc. to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
9. Media Advisory - Oncolytics Biotech Inc. to Present at Toronto CFA Society
10. Oncolytics Biotech Inc. Announces Issuance of 24th U.S. Patent
11. Oncolytics Biotech Inc. to Present at Annual Vaccine Production Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)... LASIK Surgery and vision corre... directory were actively involved at the recently ...2009 Annual Meeting in San Francisco, California. ...MD, Dr. Jonathan Davidorf, MD, Dr. Peter Rapoza, M..., Dr. R. Wayne Bowman, MD, Dr. Edward Manche, MD, ...
(Date:11/4/2009)... This webinar, which will be pr...e working in continuous flow chemistry processing,...w cell inline using various meso and micro scale f...over 670 publications has been recognized with sev... recently the 2009 Tetrahedron Prize. , ...
(Date:11/4/2009)...HUNTSVILLE, Ala., Nov. 4 DIATHERIX...om ), today presented at the Michigan Security Ne...ce in Dearborn, Mich. Dennis Grimaud, Chairman and...he impact of the company,s advanced molecular diag...nse, infectious disease diagnosis and military eff...
(Date:11/4/2009)... ,, ROCKVILLE, Md., Nov. 4 Z...mpany focused on next-generation antibody drug dev...million in Series A funding from New Enterprise As... capital firms. The capital will be used to create...t address two or more biological targets with a si...
Breaking Biology Technology:Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 2Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 3Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 4Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 5Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 6Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 7Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 8Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 9Professor Steven Ley of University of Cambridge will Present Free Webinar, 'Application of the ReactIR Flow Cell to Continuous Processing Technology' 2Professor Steven Ley of University of Cambridge will Present Free Webinar, 'Application of the ReactIR Flow Cell to Continuous Processing Technology' 3DIATHERIX Laboratories Presents at Homeland Security Conference 2Zyngenia, Inc. Raises $10 Million in Series A Funding 2Zyngenia, Inc. Raises $10 Million in Series A Funding 3Zyngenia, Inc. Raises $10 Million in Series A Funding 4
... /PRNewswire-FirstCall/ - Spectral Diagnostics Inc...its relationship with Toray,Medical Co. Ltd. for t...vity Assay (EAA(TM)), the only FDA cleared assay f...f the new collaboration agreement, Spectral,will h...ic territories,including China, India, Russia and ...
...artners with Bioscene in Japan - Expands Presence ...Xennex) announced,today that the Japan Patent Offi...nounced that it has selected Bioscene Informatics ...istribution of GeneCards in Japan., GeneCards wil...approval,of patent applications in the life scienc...
...N, May 5 /PRNewswire-FirstCall/ - YM BioSciences I... company that identifies,develops and commercializ...today announced that posters describing research c...) will be presented at The 27th Annual,Scientific ...place May,8-10, 2008 in Tampa, Florida., The firs...
Other Biology Technology:Spectral and Toray expand collaboration to include new geographic territories 2Spectral and Toray expand collaboration to include new geographic territories 3Japan Patent Office Licenses GeneCards(R) from Xennex, Inc. 2Japan Patent Office Licenses GeneCards(R) from Xennex, Inc. 3Japan Patent Office Licenses GeneCards(R) from Xennex, Inc. 4YM BIOSCIENCES ANNOUNCES PRESENTATIONS FOR AEROLEF(TM) AT AMERICAN PAIN SOCIETY ANNUAL MEETING 2
(Date:11/4/2009)...n the cities of Long Beach and Riverside are respo... childhood asthma, and the true impact of air poll... been underestimated, according to researchers at ...The study, which appears in an online edition of t...that nine percent of all childhood asthma cases in...
(Date:11/4/2009)...a at Norman has received more than $10 million in ... of the federal stimulus program, bringing thetota...chers to $23 million. Thirty-three projects achie...aeology to weather. , "The university has though...g areasof scholarly excellence to federal agency p...
(Date:11/4/2009)...20 Aware, Inc. (Nasdaq: ...y and biometrics software, today reported financia...0, 2009. ,, Michael Tzannes, Aware,s Chairman..., we announced an agreement to sell our DSL and ho...ss semiconductor company being spun out of Infineo...
Breaking Biology News(10 mins):USC study finds big air pollution impacts on local communities 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 3Aware, Inc. Reports Third Quarter 2009 Financial Results 2Aware, Inc. Reports Third Quarter 2009 Financial Results 3Aware, Inc. Reports Third Quarter 2009 Financial Results 4Aware, Inc. Reports Third Quarter 2009 Financial Results 5Aware, Inc. Reports Third Quarter 2009 Financial Results 6Aware, Inc. Reports Third Quarter 2009 Financial Results 7Verenium 1 3A12 Reverse Stock Split Takes Effect 13953 1Verenium 1 3A12 Reverse Stock Split Takes Effect 13953 2Verenium 1 3A12 Reverse Stock Split Takes Effect 13953 3Verenium 1 3A12 Reverse Stock Split Takes Effect 13953 4Brain Scans Could Help Spot Schizophrenia Earlier 56674 1Brain Scans Could Help Spot Schizophrenia Earlier 56674 2Leading Expert Available to Weigh in on Health Care Reform 56672 1Leading Expert Available to Weigh in on Health Care Reform 56672 2Leading Expert Available to Weigh in on Health Care Reform 56672 3
...arbara, Calif.) - It took a decade of painstaking ..., and a database of more than 200,000 fossil recor...he conventional wisdom about the diversity of mari...rcher with the National Center for Ecological Anal... the principal author of a report published in the...
...AA coral bleaching prediction system indicates tha...ter this year, but the event will probably not be ...bleaching outlook this week at the 11th Internatio... The system also suggests that there is a risk of... Islands in August, but little bleaching elsewhere...
...kins Ice Shelf is experiencing further disintegrat...idge connecting the shelf to Charcot Island. Since...helps to stabilise the ice shelf, it is likely the...the ice shelf at risk. , This animation, comprise...ic Aperture Radar (ASAR) between 30 May and 9 July...
Other Biology News:UCSB researcher leads worldwide study on marine fossil diversity 2New NOAA coral bleaching prediction system calls for low level of bleaching in Caribbean this year 2Wilkins Ice Shelf hanging by its last thread 2Wilkins Ice Shelf hanging by its last thread 3
...positive selection for creating baculovirus recomb...ession in insect cells. The kit improves on the tr...viruses by eliminating the time-consuming steps of... genome with a portion of the essential open readi...
...stem is intended for use in the quantitative detec...idated method for in vitro nucleic acid amplificat...he XpressPack Luminescent Detection System is a hy...fied nucleic acid specific to the target of intere...
Corning C ulture Dishes, 245 mm2 X 25 mm H, 500Cm2, Sterile from Sigma-Aldrich
...culture chambers produce cell yields in the 10 7 -...le roller bottles or spinner flasks. • High m... • 100% leak tested prior to shipping • ...adiation, with low particulate contamination from ...
Biology Products: